Xarelto manufacturer Bayer Pharmaceuticals and U.S. rights owner Johnson & Johnson have been accused of hiding information about the anticoagulant and exaggerating the drug’s efficacy. Lawyers in Xarelto lawsuits have alleged that the two companies hid the fact the drug does not contain an antidote and understated the risk of Xarelto side effects.
Thousands of adverse events have been tied to Xarelto since the drug was approved by the U.S. Food and Drug Administration (FDA) in 2011. An additional 65 Xarelto deaths were reported due to excessive bleeding from taking the drug.
Xarelto is an anticoagulant designed to reduce the risk of blood clots in patients after certain types of surgery. However, thousands of patients have suffered from Xarelto side effects, including internal hemorrhaging, excessive bleeding, pulmonary embolism and deep vein thrombosis (DVT).